DURHAM, N.C. (AP) _ Precision BioSciences Inc. (DTIL) on Wednesday reported a loss of $19.4 million in its second quarter.
The Durham, North Carolina-based company said it had a loss of 39 cents per share.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 51 cents per share.
The genome editing company posted revenue of $5.4 million in the period, which did not meet Street forecasts. Three analysts surveyed by Zacks expected $8.2 million.